Search
Descriptor English: Epoetin Alfa
Descriptor Spanish: Epoetina alfa
Descriptor epoetina alfa
Scope note: Forma recombinante glucosilada de eritropoyetina que estimula la diferenciación y proliferación de precursores eritroides. Se utiliza para el tratamiento de la ANEMIA asociada a FALLO RENAL CRÓNICO en pacientes en diálisis y prediálisis.
Descriptor Portuguese: Epoetina alfa
Descriptor French: Époétine alfa
Entry term(s): Alfa Hexal, Epoetin
Alfa, Epoetin
Binocrit
Compound, HX575
Epoetin Alfa Hexal
Epogen
Eprex
HX575
HX575 Compound
Heberitro
Hexal, Epoetin Alfa
Procrit
Recombinant 1 165 Erythropoietin, Glycoform Alpha
Recombinant 1-165 Erythropoietin, Glycoform Alpha
Tree number(s): D09.400.430.775.150.750
D12.644.276.374.410.240.150.500
D12.776.395.240.150.750
D12.776.467.374.410.240.150.500
D23.529.374.410.240.150.750
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000068817
Scope note: A recombinant glycosylated form of erythropoietin which stimulates the differentiation and proliferation of erythroid precursors. It is used for the treatment of ANEMIA associated with CHRONIC RENAL FAILURE in dialysis and predialysis patients.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BI biosynthesis
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
DE drug effects
DF deficiency
EC economics
GE genetics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PH physiology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UL ultrastructure
UR urine
Pharm Action: Hematinics
Registry Number: 64FS3BFH5W
CAS Type 1 Name: 1-165-Erythropoietin (human clone lambdaHEPOFL13 protein moiety), glycoform alpha
Public MeSH Note: 2016; EPOETIN ALFA was indexed under ERYTHROPOIETIN 2011-2015
History Note: 2016 (2011)
DeCS ID: 55967
Unique ID: D000068817
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2016/01/01
Date of Entry: 2015/07/01
Revision Date: 2015/06/16
Epoetin Alfa - Preferred
Concept UI M0028770
Scope note A recombinant glycosylated form of erythropoietin which stimulates the differentiation and proliferation of erythroid precursors. It is used for the treatment of ANEMIA associated with CHRONIC RENAL FAILURE in dialysis and predialysis patients.
Preferred term Epoetin Alfa
Entry term(s) Alfa, Epoetin
Recombinant 1 165 Erythropoietin, Glycoform Alpha
Recombinant 1-165 Erythropoietin, Glycoform Alpha
Epoetin Alfa Hexal - Narrower
Concept UI M0593995
Preferred term Epoetin Alfa Hexal
Entry term(s) Alfa Hexal, Epoetin
Hexal, Epoetin Alfa
Eprex - Narrower
Concept UI M0028767
Preferred term Eprex
Heberitro - Narrower
Concept UI M0494900
Preferred term Heberitro
Procrit - Narrower
Concept UI M000606819
Preferred term Procrit
Binocrit - Narrower
Concept UI M0593993
Preferred term Binocrit
HX575 Compound - Narrower
Concept UI M0593994
Preferred term HX575 Compound
Entry term(s) Compound, HX575
Epogen - Narrower
Concept UI M0373310
Preferred term Epogen
HX575 - Narrower
Concept UI M0542538
Preferred term HX575



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey